After posting "oustanding" pivotal trial data, Orthocell will apply for US FDA approval of its Remplir nerve-repair product.

The prices of bauxite is on a tear and Lowell Resources Fund CIO John Forwood is looking at ways to play the booming price ...

Aura Energy could reach FID in 2025 at its US$230m Tiris uranium mine in Mauritania, one of the ASX's best undeveloped mining ...

Investors have demonstrated their confidence in Everest Metals Corporation (ASX:EMC) by providing firm commitments for a ...

Another small-cap success story is Auric Mining (ASX:AWJ), the owners of tenements smack back in the middle of Kalgoorlie and ...

Tit for tat bans on uranium imports and exports by the US and Russia present a tremendous opportunity for ASX companies ...

The Rule of 40 is a metric used to assess a SaaS company’s overall performance. It adds up the company’s revenue growth and ...

Horseshoe Metals’ (ASX:HOR) review of historical data has identified new copper-gold targets at its newly expanded Horseshoe ...